Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel
- 30 September 2000
- journal article
- Published by Elsevier in Contraception
- Vol. 62 (3), 131-135
- https://doi.org/10.1016/s0010-7824(00)00153-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The effect of desogestrel, gestodene, and other factors on spotting and bleedingContraception, 1996
- A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodeneGynecological Endocrinology, 1996
- Clinical comparison of monophasic oral contraceptive preparations of gestodene/ ethinyl estradiol and desogestrel/ethinyl estradiolContraception, 1994
- A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulationAdvances in Contraception, 1994
- Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiolBJOG: An International Journal of Obstetrics and Gynaecology, 1993
- German Trial of an Oral Contraceptive Containing 0.150 mg Desogestrel Plus 0.020 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- Belgian Trial of an Oral Contraceptive Containing 0.150 mg Desogestrel and 0.020 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- A Clinical Comparison in Finland of Two Oral Contraceptives Containing 0.150 mg Desogestrel in Combination with 0.020 mg Or 0.030 mg EthinylestradiolActa Obstetricia et Gynecologica Scandinavica, 1987
- Evaluation of an Oral Contraceptive Containing 0.150 mg Desogestrel and 0.020 mg Ethinylestradiol in Women Aged 30 Years or OlderActa Obstetricia et Gynecologica Scandinavica, 1987